These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1680817)

  • 1. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice.
    Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL
    Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oestrogen stimulation of ERBB2 ectodomain shedding from BT-474 human breast cancer cells with ERBB2 gene amplification.
    Wärri AM; Isola JJ; Härkönen PL
    Eur J Cancer; 1996 Jan; 32A(1):134-40. PubMed ID: 8695221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro.
    Wärri AM; Huovinen RL; Laine AM; Martikainen PM; Härkönen PL
    J Natl Cancer Inst; 1993 Sep; 85(17):1412-8. PubMed ID: 8350365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
    Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
    Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.
    Neri C; Colomb E; Roux-Dosseto M; Martin PM
    Anticancer Res; 1991; 11(1):411-5. PubMed ID: 1826824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
    Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
    Benz CC; Scott GK; Sarup JC; Johnson RM; Tripathy D; Coronado E; Shepard HM; Osborne CK
    Breast Cancer Res Treat; 1992; 24(2):85-95. PubMed ID: 8095168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.
    Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC
    Breast Cancer Res Treat; 1990 Feb; 15(2):95-101. PubMed ID: 2138919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C; Gajdos C; Cheng D; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
    Chu I; Blackwell K; Chen S; Slingerland J
    Cancer Res; 2005 Jan; 65(1):18-25. PubMed ID: 15665275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.